Lacking Resources & Authority, WHO Was Too Slow To Act Against COVID-19 – Says Independent Review Panel 19/01/2021 Kerry Cullinan, Raisa Santos & Madeleine Hoecklin The World Health Organization’s (WHO) response to COVID-19 was too slow, hampered by an antiquated pandemic alert system, lack of resources and a lack of authority with member states, according to an interim report by the Independent Panel on Pandemic Preparedness and Response, presented to the WHO’s Executive Board meeting on Tuesday. It took the […] Continue reading -> COVID-19 Cases Spike In Brazil As New Variant Spreads, While WHO Says No Need For ‘Vaccine Passport’ Yet 15/01/2021 Madeleine Hoecklin & Kerry Cullinan Many areas of Brazil, particularly Manaus, are experiencing worsening COVID-19 outbreaks and extremely high levels of infections, amidst news of a new variant that is spreading in the country. Brazil joins countries around the world – including those in Europe, the Americas, and some parts of Africa – that are seeing spikes in cases and […] Continue reading -> As WHO Team Finally Arrives In Wuhan To Investigate SARS-CoV2 Virus Origins – Two Members Left Behind In Singapore 14/01/2021 Madeleine Hoecklin After months of delay, a pared-down WHO research team charged with investigating the origins of the SARS-CoV2 virus finally arrived in China on Thursday – but two members of the team were left behind in Singapore after they tested positive for COVID-19 antibodies, WHO said. In the 24 hours since, one of these two members […] Continue reading -> Johnson & Johnson Prepares To Release COVID Vaccine Trial Data, While US Announces Changes To Vaccination Policy 14/01/2021 Madeleine Hoecklin Johnson & Johnson is set to release its Phase 3 COVID-19 clinical trial results in two weeks and immediately file for emergency authorization from the US Food and Drug Administration (FDA) – an announcement that is likely a harbinger of positive results. This news on the development of the first one-shot COVID-19 vaccine, accompanied by […] Continue reading -> €93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> WHO Stresses That China Trip To Investigate SARS-CoV2 Virus Origins is Not About Blame; Urges All Countries to Improve Genome Sequencing Research 11/01/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) research investigation in China to study the origin of the SARS-CoV2 virus that triggered a worldwide pandemic of COVID-19 is not intended to apportion blame, Executive Director of WHO’s Health Emergencies Programme Michael Ryan stressed in a press briefing on Monday. The statement was made hours after WHO Executive Director […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> Procure And Supply Vaccines Through COVAX And Not Bilateral Deals – WHO Plea To Countries & Pharma 08/01/2021 Elaine Ruth Fletcher, James Hacker & Madeleine Hoecklin Some 42 countries around the world are now rolling out brand new COVID-19 vaccines to their populations. But 36 of those are high-income countries, 6 are middle-income countries, and none at all are low-income countries, said WHO’s Director General Dr Tedros Adhanom Ghebreyesus at a WHO press briefing on Friday. He and other WHO officials […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVID-19 Cases Spike In Brazil As New Variant Spreads, While WHO Says No Need For ‘Vaccine Passport’ Yet 15/01/2021 Madeleine Hoecklin & Kerry Cullinan Many areas of Brazil, particularly Manaus, are experiencing worsening COVID-19 outbreaks and extremely high levels of infections, amidst news of a new variant that is spreading in the country. Brazil joins countries around the world – including those in Europe, the Americas, and some parts of Africa – that are seeing spikes in cases and […] Continue reading -> As WHO Team Finally Arrives In Wuhan To Investigate SARS-CoV2 Virus Origins – Two Members Left Behind In Singapore 14/01/2021 Madeleine Hoecklin After months of delay, a pared-down WHO research team charged with investigating the origins of the SARS-CoV2 virus finally arrived in China on Thursday – but two members of the team were left behind in Singapore after they tested positive for COVID-19 antibodies, WHO said. In the 24 hours since, one of these two members […] Continue reading -> Johnson & Johnson Prepares To Release COVID Vaccine Trial Data, While US Announces Changes To Vaccination Policy 14/01/2021 Madeleine Hoecklin Johnson & Johnson is set to release its Phase 3 COVID-19 clinical trial results in two weeks and immediately file for emergency authorization from the US Food and Drug Administration (FDA) – an announcement that is likely a harbinger of positive results. This news on the development of the first one-shot COVID-19 vaccine, accompanied by […] Continue reading -> €93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> WHO Stresses That China Trip To Investigate SARS-CoV2 Virus Origins is Not About Blame; Urges All Countries to Improve Genome Sequencing Research 11/01/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) research investigation in China to study the origin of the SARS-CoV2 virus that triggered a worldwide pandemic of COVID-19 is not intended to apportion blame, Executive Director of WHO’s Health Emergencies Programme Michael Ryan stressed in a press briefing on Monday. The statement was made hours after WHO Executive Director […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> Procure And Supply Vaccines Through COVAX And Not Bilateral Deals – WHO Plea To Countries & Pharma 08/01/2021 Elaine Ruth Fletcher, James Hacker & Madeleine Hoecklin Some 42 countries around the world are now rolling out brand new COVID-19 vaccines to their populations. But 36 of those are high-income countries, 6 are middle-income countries, and none at all are low-income countries, said WHO’s Director General Dr Tedros Adhanom Ghebreyesus at a WHO press briefing on Friday. He and other WHO officials […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
As WHO Team Finally Arrives In Wuhan To Investigate SARS-CoV2 Virus Origins – Two Members Left Behind In Singapore 14/01/2021 Madeleine Hoecklin After months of delay, a pared-down WHO research team charged with investigating the origins of the SARS-CoV2 virus finally arrived in China on Thursday – but two members of the team were left behind in Singapore after they tested positive for COVID-19 antibodies, WHO said. In the 24 hours since, one of these two members […] Continue reading -> Johnson & Johnson Prepares To Release COVID Vaccine Trial Data, While US Announces Changes To Vaccination Policy 14/01/2021 Madeleine Hoecklin Johnson & Johnson is set to release its Phase 3 COVID-19 clinical trial results in two weeks and immediately file for emergency authorization from the US Food and Drug Administration (FDA) – an announcement that is likely a harbinger of positive results. This news on the development of the first one-shot COVID-19 vaccine, accompanied by […] Continue reading -> €93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> WHO Stresses That China Trip To Investigate SARS-CoV2 Virus Origins is Not About Blame; Urges All Countries to Improve Genome Sequencing Research 11/01/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) research investigation in China to study the origin of the SARS-CoV2 virus that triggered a worldwide pandemic of COVID-19 is not intended to apportion blame, Executive Director of WHO’s Health Emergencies Programme Michael Ryan stressed in a press briefing on Monday. The statement was made hours after WHO Executive Director […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> Procure And Supply Vaccines Through COVAX And Not Bilateral Deals – WHO Plea To Countries & Pharma 08/01/2021 Elaine Ruth Fletcher, James Hacker & Madeleine Hoecklin Some 42 countries around the world are now rolling out brand new COVID-19 vaccines to their populations. But 36 of those are high-income countries, 6 are middle-income countries, and none at all are low-income countries, said WHO’s Director General Dr Tedros Adhanom Ghebreyesus at a WHO press briefing on Friday. He and other WHO officials […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Johnson & Johnson Prepares To Release COVID Vaccine Trial Data, While US Announces Changes To Vaccination Policy 14/01/2021 Madeleine Hoecklin Johnson & Johnson is set to release its Phase 3 COVID-19 clinical trial results in two weeks and immediately file for emergency authorization from the US Food and Drug Administration (FDA) – an announcement that is likely a harbinger of positive results. This news on the development of the first one-shot COVID-19 vaccine, accompanied by […] Continue reading -> €93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> WHO Stresses That China Trip To Investigate SARS-CoV2 Virus Origins is Not About Blame; Urges All Countries to Improve Genome Sequencing Research 11/01/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) research investigation in China to study the origin of the SARS-CoV2 virus that triggered a worldwide pandemic of COVID-19 is not intended to apportion blame, Executive Director of WHO’s Health Emergencies Programme Michael Ryan stressed in a press briefing on Monday. The statement was made hours after WHO Executive Director […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> Procure And Supply Vaccines Through COVAX And Not Bilateral Deals – WHO Plea To Countries & Pharma 08/01/2021 Elaine Ruth Fletcher, James Hacker & Madeleine Hoecklin Some 42 countries around the world are now rolling out brand new COVID-19 vaccines to their populations. But 36 of those are high-income countries, 6 are middle-income countries, and none at all are low-income countries, said WHO’s Director General Dr Tedros Adhanom Ghebreyesus at a WHO press briefing on Friday. He and other WHO officials […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
€93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> WHO Stresses That China Trip To Investigate SARS-CoV2 Virus Origins is Not About Blame; Urges All Countries to Improve Genome Sequencing Research 11/01/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) research investigation in China to study the origin of the SARS-CoV2 virus that triggered a worldwide pandemic of COVID-19 is not intended to apportion blame, Executive Director of WHO’s Health Emergencies Programme Michael Ryan stressed in a press briefing on Monday. The statement was made hours after WHO Executive Director […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> Procure And Supply Vaccines Through COVAX And Not Bilateral Deals – WHO Plea To Countries & Pharma 08/01/2021 Elaine Ruth Fletcher, James Hacker & Madeleine Hoecklin Some 42 countries around the world are now rolling out brand new COVID-19 vaccines to their populations. But 36 of those are high-income countries, 6 are middle-income countries, and none at all are low-income countries, said WHO’s Director General Dr Tedros Adhanom Ghebreyesus at a WHO press briefing on Friday. He and other WHO officials […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Stresses That China Trip To Investigate SARS-CoV2 Virus Origins is Not About Blame; Urges All Countries to Improve Genome Sequencing Research 11/01/2021 Kerry Cullinan & Madeleine Hoecklin The World Health Organization (WHO) research investigation in China to study the origin of the SARS-CoV2 virus that triggered a worldwide pandemic of COVID-19 is not intended to apportion blame, Executive Director of WHO’s Health Emergencies Programme Michael Ryan stressed in a press briefing on Monday. The statement was made hours after WHO Executive Director […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> Procure And Supply Vaccines Through COVAX And Not Bilateral Deals – WHO Plea To Countries & Pharma 08/01/2021 Elaine Ruth Fletcher, James Hacker & Madeleine Hoecklin Some 42 countries around the world are now rolling out brand new COVID-19 vaccines to their populations. But 36 of those are high-income countries, 6 are middle-income countries, and none at all are low-income countries, said WHO’s Director General Dr Tedros Adhanom Ghebreyesus at a WHO press briefing on Friday. He and other WHO officials […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> Procure And Supply Vaccines Through COVAX And Not Bilateral Deals – WHO Plea To Countries & Pharma 08/01/2021 Elaine Ruth Fletcher, James Hacker & Madeleine Hoecklin Some 42 countries around the world are now rolling out brand new COVID-19 vaccines to their populations. But 36 of those are high-income countries, 6 are middle-income countries, and none at all are low-income countries, said WHO’s Director General Dr Tedros Adhanom Ghebreyesus at a WHO press briefing on Friday. He and other WHO officials […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Procure And Supply Vaccines Through COVAX And Not Bilateral Deals – WHO Plea To Countries & Pharma 08/01/2021 Elaine Ruth Fletcher, James Hacker & Madeleine Hoecklin Some 42 countries around the world are now rolling out brand new COVID-19 vaccines to their populations. But 36 of those are high-income countries, 6 are middle-income countries, and none at all are low-income countries, said WHO’s Director General Dr Tedros Adhanom Ghebreyesus at a WHO press briefing on Friday. He and other WHO officials […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older posts